RESEARCH & DEVELOPMENT PROJECTS
Bravo Pharma companies have carried out the following R&D projects:
- * Identification and characterization of inhibitors of molecular pathways linked to cancer
- * Mechanism studies and pre-clinical development of novel angiogenesis inhibitor
- * Cellular immunotherapy
- * Pre-clinical development of targeted therapy against melanoma
- * Pre-clinical and clinical development of drug candidate against rare blood cancers
- * Pre-clinical and clinical studies of combination therapy for hormone sensitive cancers
- * Bioenergetics of cancer cell
- * Therapeutic antibodies